Drug Side Effects
Search
PARVOVIRUS B19 INFECTION REACTIVATION
PARVOVIRUS B19 INFECTION REACTIVATION
was reported 32 times
PARVOVIRUS B19 INFECTION REACTIVATION is most prevalent among patients taking these drugs:
#
Drug
Count
Frequency
0
MYCOPHENILIC ACID
11
0.0005
1
SIROLIMUS
7
0.0005
2
CEFOTAXIME INJECTION
2
0.0005
3
TECLISTAMAB-CQYV
1
0.0004
4
(DAUNORUBICIN AND CYTARABINE) LIPOSOME
1
0.0004
5
MYCOPHENOLIC ACID
11
0.0003
6
HUMAN IMMUNOGLOBULIN G
4
0.0002
7
GANCICLOVIR SODIUM
2
0.0002
8
EVEROLIMUS TABLETS
3
0.0002
9
TACROLIMUS OINTMENT 0.1%
18
0.0001
10
TACROLIMUS EXTENDED-RELEASE CAPSULES
18
0.0001
11
TACROLIMUS
19
0.0001
12
VALGANCICLOVIR
2
0.0001
13
CYCLOSPORINE
8
0.0001
14
BUSULFAN
1
0.0001
15
EVEROLIMUS
3
0.0001
16
ALEMTUZUMAB
1
0.0001
17
MYCOPHENOLATE MOFETIL
7
0.0001
18
FLUDARABINE PHOSPHATE
2
0.0001
19
RITUXIMAB
10
0.0000
20
METRONIDAZOLE TOPICAL
2
0.0000
21
MELPHALAN HYDROCHLORIDE
1
0.0000
22
VANCOMYCIN
2
0.0000
23
METRONIDAZOLE
2
0.0000
24
RUXOLITINIB
2
0.0000
25
METHYLPREDNISOLONE SODIUM SUCCINATE
1
0.0000
26
PREDNISONE
7
0.0000
27
SULFAMETHOXAZOLE AND TRIMETHOPRIM
1
0.0000
28
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
1
0.0000
29
METHYLPREDNISOLONE
1
0.0000
30
CYCLOPHOSPHAMIDE FOR INJECTION
1
0.0000
31
CYCLOPHOSPHAMIDE
1
0.0000
32
PREDNISOLONE ORAL SOLUTION
1
0.0000
33
METHOTREXATE SODIUM
2
0.0000